Aug-14-09
NuPathe Inc. from Conshohocken, PA has just announced positive results from their clinical trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraines.
Zelrix relies on the company's proprietary technology called SmartRelief™ to continuously deliver sumatriptan for the treatment of migraines. Zelrix, is "a thin, disposable, single-use device in a self-contained system," made to give migraine sufferers a new therapeutic option with a proven medication, so they can stick on a patch and get medication fast and consistently, regardless of nausea, vomiting, or other gastric symptoms associated with migraine.
More Info about this Invention:
[
MEDGADGET.COM]
Add Your Comment